International Journal of Health and Clinical Research

Yazarlar: Pandurangaiah R, Leela GR

Konular:-

Anahtar Kelimeler:Methylprednisolone,Dexamethasone,COVID,9,Pneumonia.

Özet: Background: Increasing in the number of covid-19 cases and increasing in mortality needs an early attention in treating the inflammation to avoid patient entering to ICU, varies methods and drugs are under trial we use corticosteroid, methylprednisolone and dexamethasone its effect and safety of COVID-19 pneumonia.Methodology:Comparative study of 100 covid-19 pneumonia patient in Kannur medical college for 3 months from Sept 2020. 50 patients given methylprednisolone and other 50patient given dexamethasone.Results: Patients are randomly selected for each group to give corticosteroids,In methylprednisolone group mean age in 47yrs. 59 males, 41 females, and 29.5 averagesBMI. In Dexamethasone 49yrs mean age, 62males, 38females with32 average BMI. 45 patients are recovered with 5 deaths in methylprednisolone and 44 recovered and 6deaths in dexamethasone.Conclusion:Both dexamethasone and methylprednisolone both are equally effective in controlling covid-19 pneumonia.

---